Johnson & Johnson (JNJ)
218.33
-0.22
(-0.10%)
USD |
NYSE |
Jan 15, 11:57
Johnson & Johnson Market Cap: 526.02B for Jan. 15, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 177.55B |
| Gilead Sciences, Inc. | 152.34B |
| Eli Lilly & Co. | 914.62B |
| Regeneron Pharmaceuticals, Inc. | 78.45B |
| Protagonist Therapeutics, Inc. | 5.389B |
Market Cap Related Metrics
| PE Ratio | 21.07 |
| PS Ratio | 5.745 |
| PEG Ratio | 0.2956 |
| Price to Book Value | 6.635 |
| Price to Free Cash Flow | 25.87 |
| Price | 218.33 |
| Earnings Yield | 4.75% |
| PEGY Ratio | 0.2861 |
| Operating PE Ratio | 22.28 |
| Normalized PE Ratio | 25.61 |